Newswise — New Brunswick, N.J., May 26, 2015 – David Mulvihill, MD, chief resident of radiation oncology at Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital, has been selected to receive a Young Investigator Award from the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO). Dr. Mulvihill will be recognized at the ASCO Annual Meeting that begins later this week in Chicago.

According to the Foundation, the award is given to “promising investigators to encourage and promote quality research in clinical oncology.” Mulvihill, a resident of East Brunswick, will receive $50,000 to support his study entitled “Childhood Radiation Exposure from Interventional Cardiology Procedures and Subsequent Cancer Risk.”

Cancer Institute of New Jersey radiation oncologist, Sharad Goyal, MD, who is also an associate professor of radiation oncology at Robert Wood Johnson Medical School, is one of Mulvihill’s mentors on the project. “The receipt of this prestigious grant will provide Dr. Mulvihill with funding and protected research time to develop a productive cancer research career in his final year of training. His research project spans several fields within medicine, including pediatrics, cardiology, radiology, and oncology, and ultimately will have a high-impact within these fields,” notes Dr. Goyal.

John B. Kostis, MD, the John G. Detwiler Professor of Cardiology, associate dean for cardiovascular research, and director of the Cardiovascular Institute of New Jersey, , at Robert Wood Johnson Medical School, is the other mentor on the grant. Other collaborators include Ning ‘Jeff’ Yue, PhD, professor and vice chair, and chief of physics in the Department of Radiation Oncology at the Cancer Institute and Robert Wood Johnson Medical School; Antoinette Stroup, PhD, resident member of the Cancer Institute, director of the New Jersey State Cancer Registry and associate professor and chief of the Division of Cancer Epidemiology at Rutgers School of Public Health; and Jerry Cheng, PhD, assistant professor of medicine at the Cardiovascular Institute of New Jersey, part of the Robert Wood Johnson Medical School. The one year grant starts July 1.

About The Cancer Institute of New JerseyThe Cancer Institute of New Jersey (www.cinj.org) is the state’s first and only National Cancer Institute-designated Comprehensive Cancer Center dedicated to improving the detection, treatment and care of patients with cancer, and serving as an education resource for cancer prevention. Physician-scientists at The Cancer Institute of New Jersey engage in translational research, transforming their laboratory discoveries into clinical practice, quite literally bringing research to life. To make a tax-deductible gift to support The Cancer Institute of New Jersey, call 732-235-8614 or visit www.cinjfoundation.org. Follow us on Facebook at www.facebook.com/TheCINJ.

The Cancer Institute of New Jersey Network is comprised of hospitals throughout the state and provides the highest quality cancer care and rapid dissemination of important discoveries into the community. Flagship Hospital: Robert Wood Johnson University Hospital. System Partner: Meridian Health (Jersey Shore University Medical Center, Ocean Medical Center, Riverview Medical Center, Southern Ocean Medical Center, and Bayshore Community Hospital). Major Clinical Research Affiliate Hospitals: Carol G. Simon Cancer Center at Morristown Medical Center and Carol G. Simon Cancer Center at Overlook Medical Center. Affiliate Hospitals: JFK Medical Center, Robert Wood Johnson University Hospital Hamilton (CINJ Hamilton), and Robert Wood Johnson University Hospital Somerset.

###

MEDIA CONTACT
Register for reporter access to contact details
CITATIONS

ASCO Annual Meeting 2015